4Filed Aug 25, 8:00 PM ET

Edwards Lifesciences CVP Daveen Chopra Exercises Options, Sells Shares

$EW · Edwards Lifesciences Corp

Research Summary

AI-generated summary of this SEC filing

Updated

Edwards Lifesciences CVP Daveen Chopra Exercises Options, Sells Shares

What Happened

  • Daveen Chopra, CVP, TMTT, Surgical & IHFM at Edwards Lifesciences (EW), exercised 31,800 options (code M) on August 26, 2026 at an exercise price of $72.68 per share, paying $2,311,224. The same day he disposed of 31,800 shares via open-market sales in multiple trades, receiving total proceeds of $2,894,440. The net pre-tax cash difference between sale proceeds and exercise cost was about $583,216. This sequence reads as a same‑day exercise and sale (commonly a cashless exercise), i.e., effectively a disposition rather than a long-term purchase.

Key Details

  • Transaction date: August 26, 2026.
  • Exercise: 31,800 shares at $72.68 — total cost $2,311,224 (code M, acquired).
  • Sales: total 31,800 shares sold in multiple trades:
    • 1,154 shares at a weighted average $91.76 — proceeds $105,893 (F1: trades ranged $91.660–$91.975).
    • 30,646 shares at a weighted average $90.99 — proceeds $2,788,547 (F2: trades ranged $90.645–$91.640).
  • Total sale proceeds: $2,894,440. Net pre-tax difference vs exercise cost ≈ $583,216.
  • The Form 4 also lists a derivative disposition of 31,800 shares at $0 (M), reflecting the exercise/disposition reporting — see filing for mechanics.
  • Shares owned after the transaction: not stated in the provided filing excerpt.
  • Filing timing: transaction and Form 4 are dated the same day (Aug 26, 2026); no late‑filing indication in the provided data.
  • Remarks: the filing notes it "reflects changes in beneficial ownership only."

Context

  • When an insider exercises options and immediately sells the shares, it commonly indicates a liquidity-driven action (e.g., exercising vested options and selling to cover costs or take gains) rather than a buy signal; factual reporting shows exercised options followed by same‑day sales here.
  • Footnotes F1 and F2 explain the sales were executed in multiple trades; weighted averages are reported and the filer will provide detailed per-trade info on request to the SEC, issuer, or a security holder.